These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35883418)

  • 21. High-mass MALDI-MS unravels ligand-mediated G protein-coupling selectivity to GPCRs.
    Wu N; Olechwier AM; Brunner C; Edwards PC; Tsai CJ; Tate CG; Schertler GFX; Schneider G; Deupi X; Zenobi R; Ma P
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
    Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
    J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding site identification of G protein-coupled receptors through a 3D Zernike polynomials-based method: application to C. elegans olfactory receptors.
    Di Rienzo L; De Flaviis L; Ruocco G; Folli V; Milanetti E
    J Comput Aided Mol Des; 2022 Jan; 36(1):11-24. PubMed ID: 34977999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?
    Vass M; Kooistra AJ; Verhoeven S; Gloriam D; de Esch IJP; de Graaf C
    Methods Mol Biol; 2018; 1705():73-113. PubMed ID: 29188559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.
    Cavasotto CN; Orry AJ; Abagyan RA
    Proteins; 2003 May; 51(3):423-33. PubMed ID: 12696053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From three-dimensional GPCR structure to rational ligand discovery.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    Adv Exp Med Biol; 2014; 796():129-57. PubMed ID: 24158804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors.
    Gruber CW; Muttenthaler M; Freissmuth M
    Curr Pharm Des; 2010; 16(28):3071-88. PubMed ID: 20687879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and biophysical characterisation of G protein-coupled receptor ligand binding using resonance energy transfer and fluorescent labelling techniques.
    Ward RJ; Milligan G
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt A):3-14. PubMed ID: 23590995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic Use of GPCR Modeling and SDM Experiments to Understand Ligand Binding.
    Potterton A; Heifetz A; Townsend-Nicholson A
    Methods Mol Biol; 2018; 1705():335-343. PubMed ID: 29188570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios.
    Di Pizio A; Levit A; Slutzki M; Behrens M; Karaman R; Niv MY
    Methods Cell Biol; 2016; 132():401-27. PubMed ID: 26928553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing common substructures of ligands for GPCR protein subfamilies.
    Erguner B; Hattori M; Goto S; Kanehisa M
    Genome Inform; 2010; 24():31-41. PubMed ID: 22081587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.
    Szwabowski GL; Griffing M; Mugabe EJ; O'Malley D; Baker LN; Baker DL; Parrill AL
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural features embedded in G protein-coupled receptor co-crystal structures are key to their success in virtual screening.
    Coudrat T; Christopoulos A; Sexton PM; Wootten D
    PLoS One; 2017; 12(4):e0174719. PubMed ID: 28380046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homology model-assisted elucidation of binding sites in GPCRs.
    Levit A; Barak D; Behrens M; Meyerhof W; Niv MY
    Methods Mol Biol; 2012; 914():179-205. PubMed ID: 22976029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors.
    Vu O; Bender BJ; Pankewitz L; Huster D; Beck-Sickinger AG; Meiler J
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benchmarking GPCR homology model template selection in combination with de novo loop generation.
    Szwabowski GL; Castleman PN; Sears CK; Wink LH; Cole JA; Baker DL; Parrill AL
    J Comput Aided Mol Des; 2020 Oct; 34(10):1027-1044. PubMed ID: 32737667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.